Clinical Evaluation of (68)Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α(v)β(3) in Various Cancer Types

Radiolabeled fibroblast activation protein (FAP) inhibitors (FAPIs) and Arg-Gly-Asp (RGD) peptides have been extensively investigated for imaging of FAP- and integrin α(v)β(3)–positive tumors. In this study, a FAPI-RGD heterodimer was radiolabeled with (68)Ga and evaluated in patients with cancer. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Liang, Wen, Xuejun, Xu, Weizhi, Pang, Yizhen, Sun, Long, Wu, Xiaoming, Xu, Pengfei, Zhang, Jingjing, Guo, Zhide, Lin, Qin, Chen, Xiaoyuan, Chen, Haojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394316/
https://www.ncbi.nlm.nih.gov/pubmed/37142301
http://dx.doi.org/10.2967/jnumed.122.265383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394316/
https://www.ncbi.nlm.nih.gov/pubmed/37142301
http://dx.doi.org/10.2967/jnumed.122.265383

Ejemplares similares